| 词条 | Mepiprazole |
| 释义 |
| IUPAC_name = 1-(3-Chlorophenyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethyl]piperazine | image = Mepiprazole structure.svg | tradename = Psigodal | pregnancy_category = | legal_status = Rx-only | routes_of_administration = Oral | bioavailability = | metabolism = | elimination_half-life = | excretion = | CAS_number = 20326-12-9 | CAS_supplemental = 20344-15-4 (hydrochloride) | ATC_prefix = none | ATC_suffix = | PubChem = 71897 | ChemSpiderID = 64909 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 977BAL0NR7 | synonyms = PAP, EMD-16923, H-4007 | C=16 | H=21 | Cl=1 | N=4 | molecular_weight = 304.82 g/mol | smiles = Cc3cc(CCN2CCN(c1cccc(Cl)c1)CC2)n[nH]3 }}Mepiprazole (INN, BAN) (brand name Psigodal) is an anxiolytic drug of the phenylpiperazine group with additional antidepressant properties[1] that is marketed in Spain.[1][2][3][4][5] It acts as a 5-HT2A and α1-adrenergic receptor antagonist[6][7][8] and inhibits the reuptake and induces the release of serotonin, dopamine, and norepinephrine to varying extents,[9][8] and has been described as a serotonin antagonist and reuptake inhibitor (SARI).[10] Controlled clinical trials of mepiprazole in patients with irritable bowel syndrome (IBS) were also carried out and suggested some benefits of the drug in relieving symptoms of IBS in some patients.[11] Similarly to other phenylpiperazines like trazodone, nefazodone, and etoperidone, mepiprazole produces mCPP as an active metabolite.[12] See also
References1. ^{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA768|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=768–}} {{Anxiolytics}}{{Adrenergic receptor modulators}}{{Serotonin receptor modulators}}{{Monoamine releasing agents}}{{Piperazines}}{{Nervous-system-drug-stub}}2. ^{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | pages = | isbn = 3-88763-075-0 | oclc = | doi = | url = https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA648&dq=mepiprazole&pg=PA648#v=onepage&q&f=false}} 3. ^{{cite journal | author = Pöldinger W | title = Clinical trial of 3-methyl-5-(beta-N'-(N-m-chlorophenylpiperazino)ethyl)-pyrazole dihydrochloride (Mepiprazol) in the therapy of psychovegetative disorders | journal = International Pharmacopsychiatry | volume = 10 | issue = 1 | pages = 1–8 | year = 1975 | pmid = 1095510 | doi = | url = }} 4. ^{{cite journal |vauthors=De Buck R, Van Durme R, Pelc I | title = [A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders] | language = French | journal = Acta Psychiatrica Belgica | volume = 75 | issue = 3 | pages = 320–33 |date=May 1975 | pmid = 769484 | doi = | url = }} 5. ^{{cite journal |vauthors=Saldaña Hernández OH, Hernández González J | title = [Psychopharmological research with EMD 16-923 in patients with different degrees of anxiety] | language = Spanish| journal = Neurología, Neurocirugía, Psiquiatría | volume = 17 | issue = 1 | pages = 29–33 | year = 1976 | pmid = 1052713 | doi = | url = }} 6. ^{{cite journal |vauthors=Cohen ML, Fuller RW, Kurz KD | title = Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats | journal = Hypertension | volume = 5 | issue = 5 | pages = 676–81 | year = 1983 | pmid = 6311738 | doi = 10.1161/01.hyp.5.5.676| url = http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=6311738}} 7. ^{{cite journal |vauthors=Maj J, Sypniewska M | title = Central action of mepiprazole | journal = Polish Journal of Pharmacology and Pharmacy | volume = 32 | issue = 4 | pages = 475–84 | year = 1980 | pmid = 7255266 | doi = | url = }} 8. ^1 {{cite journal |vauthors=Fuxe K, Agnati LF, Ungerstedt U | title = The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity | journal = European Journal of Pharmacology | volume = 35 | issue = 1 | pages = 93–108 |date=January 1976 | pmid = 943291 | doi = 10.1016/0014-2999(76)90304-6| url = }} 9. ^1 {{cite journal |vauthors=Placheta P, Singer E, Kriwanek W, Hertting G | title = Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes | journal = Psychopharmacology | volume = 48 | issue = 3 | pages = 295–301 |date=August 1976 | pmid = 9660 | doi = 10.1007/BF00496865| url = }} 10. ^{{cite journal|last1=Fagiolini|first1=Andrea|last2=Comandini|first2=Alessandro|last3=Dell’Osso|first3=Mario Catena|last4=Kasper|first4=Siegfried|title=Rediscovering Trazodone for the Treatment of Major Depressive Disorder|journal=CNS Drugs|volume=26|issue=12|year=2012|pages=1033–1049|issn=1172-7047|doi=10.1007/s40263-012-0010-5|pmid=23192413|pmc=3693429}} 11. ^{{cite journal |vauthors=Dotevall G, Groll E | title = Controlled clinical trial of mepiprazole in irritable bowel syndrome | journal = The British Medical Journal | volume = 4 | issue = 5935 | pages = 16–8 |date=October 1974 | pmid = 4609545 | doi = 10.1136/bmj.4.5935.16| pmc=1612118}} 12. ^{{cite journal |vauthors=Fong MH, Garattini S, Caccia S | title = 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole | journal = The Journal of Pharmacy and Pharmacology | volume = 34 | issue = 10 | pages = 674–5 |date=October 1982 | pmid = 6128394 | doi = 10.1111/j.2042-7158.1982.tb04701.x| url = }} 6 : 5-HT2A antagonists|Alpha-1 blockers|Chloroarenes|Piperazines|Pyrazoles|Serotonin-norepinephrine-dopamine releasing agents |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。